FN1
This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. The encoded preproprotein is proteolytically processed to generate the mature protein. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. The full-length nature of some variants has not been determined.
Full Name
Fibronectin 1
Alternative Names
FN; CIG; FNZ; MSF; ED-B; FINC; GFND; LETS; GFND2; SMDCF
Function
Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin (PubMed:3024962, PubMed:3900070, PubMed:3593230, PubMed:7989369).
Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape (PubMed:3024962, PubMed:3900070, PubMed:3593230, PubMed:7989369).
Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization (By similarity).
Participates in the regulation of type I collagen deposition by osteoblasts (By similarity).
Anastellin:
Binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling.
Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape (PubMed:3024962, PubMed:3900070, PubMed:3593230, PubMed:7989369).
Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization (By similarity).
Participates in the regulation of type I collagen deposition by osteoblasts (By similarity).
Anastellin:
Binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling.
Biological Process
Acute-phase response Source: UniProtKB-KW
Angiogenesis Source: UniProtKB-KW
Biological process involved in interaction with symbiont Source: CAFA
Blood coagulation, fibrin clot formation Source: GO_Central
Calcium-independent cell-matrix adhesion Source: Ensembl
Cell adhesion Source: UniProtKB
Cell-matrix adhesion Source: GO_Central
Cell-substrate junction assembly Source: GO_Central
Endodermal cell differentiation Source: UniProtKB
Heart development Source: GO_Central
Integrin activation Source: UniProtKB
Integrin-mediated signaling pathway Source: BHF-UCL
Negative regulation of transforming growth factor beta production Source: UniProtKB
Nervous system development Source: GO_Central
Neural crest cell migration involved in autonomic nervous system development Source: MGI
Peptide cross-linking Source: BHF-UCL
Platelet aggregation Source: GO_Central
Positive regulation of axon extension Source: Ensembl
Positive regulation of cell population proliferation Source: UniProtKB
Positive regulation of fibroblast proliferation Source: UniProtKB
Positive regulation of gene expression Source: UniProtKB
Positive regulation of phosphatidylinositol 3-kinase signaling Source: BHF-UCL
Positive regulation of substrate-dependent cell migration, cell attachment to substrate Source: UniProtKB
Regulation of cell shape Source: UniProtKB-KW
Regulation of ERK1 and ERK2 cascade Source: UniProtKB
Regulation of protein phosphorylation Source: UniProtKB
Response to wounding Source: UniProtKB
Substrate adhesion-dependent cell spreading Source: BHF-UCL
Angiogenesis Source: UniProtKB-KW
Biological process involved in interaction with symbiont Source: CAFA
Blood coagulation, fibrin clot formation Source: GO_Central
Calcium-independent cell-matrix adhesion Source: Ensembl
Cell adhesion Source: UniProtKB
Cell-matrix adhesion Source: GO_Central
Cell-substrate junction assembly Source: GO_Central
Endodermal cell differentiation Source: UniProtKB
Heart development Source: GO_Central
Integrin activation Source: UniProtKB
Integrin-mediated signaling pathway Source: BHF-UCL
Negative regulation of transforming growth factor beta production Source: UniProtKB
Nervous system development Source: GO_Central
Neural crest cell migration involved in autonomic nervous system development Source: MGI
Peptide cross-linking Source: BHF-UCL
Platelet aggregation Source: GO_Central
Positive regulation of axon extension Source: Ensembl
Positive regulation of cell population proliferation Source: UniProtKB
Positive regulation of fibroblast proliferation Source: UniProtKB
Positive regulation of gene expression Source: UniProtKB
Positive regulation of phosphatidylinositol 3-kinase signaling Source: BHF-UCL
Positive regulation of substrate-dependent cell migration, cell attachment to substrate Source: UniProtKB
Regulation of cell shape Source: UniProtKB-KW
Regulation of ERK1 and ERK2 cascade Source: UniProtKB
Regulation of protein phosphorylation Source: UniProtKB
Response to wounding Source: UniProtKB
Substrate adhesion-dependent cell spreading Source: BHF-UCL
Cellular Location
Extracellular matrix
Involvement in disease
Glomerulopathy with fibronectin deposits 2 (GFND2):
Genetically heterogeneous autosomal dominant disorder characterized clinically by proteinuria, microscopic hematuria, and hypertension that leads to end-stage renal failure in the second to fifth decade of life.
Spondylometaphyseal dysplasia, corner fracture type (SMDCF):
An autosomal dominant form of spondylometaphyseal dysplasia, a group of short stature disorders distinguished by abnormalities in the vertebrae and the metaphyses of the tubular bones. SMDCF is characterized by flake-like, triangular, or curvilinear ossification centers at the edges of irregular metaphyses that simulate fractures. These corner fractures involve the distal tibia, the ulnar aspect of the distal radius, the proximal humerus, and the proximal femur. They represent irregular ossification at the growth plates and secondary ossification centers.
Genetically heterogeneous autosomal dominant disorder characterized clinically by proteinuria, microscopic hematuria, and hypertension that leads to end-stage renal failure in the second to fifth decade of life.
Spondylometaphyseal dysplasia, corner fracture type (SMDCF):
An autosomal dominant form of spondylometaphyseal dysplasia, a group of short stature disorders distinguished by abnormalities in the vertebrae and the metaphyses of the tubular bones. SMDCF is characterized by flake-like, triangular, or curvilinear ossification centers at the edges of irregular metaphyses that simulate fractures. These corner fractures involve the distal tibia, the ulnar aspect of the distal radius, the proximal humerus, and the proximal femur. They represent irregular ossification at the growth plates and secondary ossification centers.
PTM
Sulfated.
It is not known whether both or only one of Thr-2155 and Thr-2156 are/is glycosylated.
Forms covalent cross-links mediated by a transglutaminase, such as F13A or TGM2, between a glutamine and the epsilon-amino group of a lysine residue, forming homopolymers and heteropolymers (e.g. fibrinogen-fibronectin, collagen-fibronectin heteropolymers).
Phosphorylated by FAM20C in the extracellular medium.
Proteolytic processing produces the C-terminal NC1 peptide, anastellin.
Some lysine residues are oxidized to allysine by LOXL3, promoting fibronectin activation and matrix formation.
Serotonylated on Gln residues by TGM2 in response to hypoxia.
It is not known whether both or only one of Thr-2155 and Thr-2156 are/is glycosylated.
Forms covalent cross-links mediated by a transglutaminase, such as F13A or TGM2, between a glutamine and the epsilon-amino group of a lysine residue, forming homopolymers and heteropolymers (e.g. fibrinogen-fibronectin, collagen-fibronectin heteropolymers).
Phosphorylated by FAM20C in the extracellular medium.
Proteolytic processing produces the C-terminal NC1 peptide, anastellin.
Some lysine residues are oxidized to allysine by LOXL3, promoting fibronectin activation and matrix formation.
Serotonylated on Gln residues by TGM2 in response to hypoxia.
View more
Anti-FN1 antibodies
+ Filters
Loading...
Target: FN1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 71
Application*: E, B, IF, WB
Target: FN1
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Chicken
Clone: D6
Application*: E, IF, IH, IP, WB
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: 75
Application*: WB, IP, IF, P
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: CBXF-3106
Application*: WB, IP, IF, P
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: 16E5
Application*: WB, IP, IF, P, E
Target: FN1
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human, Mouse, Rat
Clone: F1
Application*: WB, IP, IF, P, E
Target: FN1
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human, Mouse
Clone: F14
Application*: WB, P, IF
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat, Pig, Dog
Clone: 3E2
Application*: WB, IP, IF, P
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: H1
Application*: WB, IP, IF, P
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: A32
Application*: WB, IP, IF, P
Target: FN1
Host: Mouse
Antibody Isotype: IgM, κ
Specificity: Human, Mouse, Rat
Clone: A17
Application*: WB, IP, IF, P
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: CBXF-0795
Application*: WB, IP, IF, P, F
Target: FN1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: G7
Application*: WB, IP, IF, P
Target: FN1
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 1E1
Application*: E, IH
Target: FN1
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 25A1
Application*: E, F
Target: FN1
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: 15D11
Application*: E, F
Target: FN1
Host: Mouse
Antibody Isotype: IgG
Specificity: Human, Mouse, Rat
Clone: 19G4
Application*: E, WB
Target: FN1
Host: Mouse
Antibody Isotype: IgG
Specificity: Human, Mouse, Rat
Clone: 29E4
Application*: E, WB
Target: FN1
Host: Mouse
Antibody Isotype: IgG
Specificity: Human, Mouse, Rat
Clone: CBT36
Application*: WB, P, IF, IC
Target: FN1
Host: Mouse
Antibody Isotype: IgG
Specificity: Mouse, Rat, Human
Clone: CBT561
Application*: WB
Target: FN1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT2527
Application*: IH, F
Target: FN1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT4156
Application*: F
Target: FN1
Host: Mouse
Antibody Isotype: IgG
Specificity: Human, Mouse, Rat
Clone: EC150
Application*: WB, P, IF
Target: FN1
Host: Mouse
Antibody Isotype: IgG
Specificity: Mouse, Rat
Clone: EC149
Application*: WB
Target: FN1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Frog
Clone: 4H2
Application*: IF, WB
More Infomation
Hot products 
-
Mouse Anti-BrdU Recombinant Antibody (IIB5) (CBMAB-1038CQ)
-
Mouse Anti-CEMIP Recombinant Antibody (3C12) (CBMAB-K0296-LY)
-
Mouse Anti-DHFR Recombinant Antibody (D0821) (CBMAB-D0821-YC)
-
Mouse Anti-BRCA2 Recombinant Antibody (CBYY-0790) (CBMAB-0793-YY)
-
Mouse Anti-BIRC7 Recombinant Antibody (88C570) (CBMAB-L0261-YJ)
-
Rat Anti-CCR2 Recombinant Antibody (475301) (CBMAB-C1338-LY)
-
Mouse Anti-ACLY Recombinant Antibody (V2-179314) (CBMAB-A0610-YC)
-
Mouse Anti-CD2AP Recombinant Antibody (BR083) (CBMAB-BR083LY)
-
Mouse Anti-BSN Recombinant Antibody (219E1) (CBMAB-1228-CN)
-
Mouse Anti-ATP1B1 Recombinant Antibody (E4) (CBMAB-0463-LY)
-
Mouse Anti-EIF4G1 Recombinant Antibody (2A9) (CBMAB-A2544-LY)
-
Mouse Anti-BHMT Recombinant Antibody (CBYY-0547) (CBMAB-0550-YY)
-
Mouse Anti-CD46 Recombinant Antibody (CBFYC-0076) (CBMAB-C0085-FY)
-
Mouse Anti-DMD Recombinant Antibody (D1190) (CBMAB-D1190-YC)
-
Mouse Anti-CIITA Recombinant Antibody (CBLC160-LY) (CBMAB-C10987-LY)
-
Mouse Anti-DLG1 Monolconal Antibody (4F3) (CBMAB-0225-CN)
-
Mouse Anti-ENO2 Recombinant Antibody (H14) (CBMAB-E1341-FY)
-
Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)
-
Mouse Anti-CD164 Recombinant Antibody (CBFYC-0077) (CBMAB-C0086-FY)
-
Rat Anti-ADAM10 Recombinant Antibody (V2-179741) (CBMAB-A1103-YC)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry




